Activin A immunoexpression as predictor of occult lymph node metastasis and overall survival in oral tongue squamous cell carcinoma

Head and Neck

Volumn 37, Issue 4, 2015, Pages 479-486

  Kelner, Natalie ^a   Rodrigues, Priscila Campioni ^b   Bufalino, Andreia ^b   Fonseca, Felipe Paiva ^b   Dos Santos Silva, Alan Roger ^b   Miguel, Marcia Cristina Costa ^b,c   Pinto, Clõvis Antonio Lopes ^a   Leme, Adriana Franco Paes ^d   Graner, Edgard ^b   Salo, Tuula ^e   Kowalski, Luiz Paulo ^a   Coletta, Ricardo D ^b  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^d BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

^e OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

activin A; carcinoma associated fibroblast; clinicopathological features; oral tongue squamous cell carcinoma; prognosis

Indexed keywords

ACTIVIN A; ACTIVIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; DRINKING BEHAVIOR; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING HABIT; TONGUE CARCINOMA; TUMOR INVASION; HEAD AND NECK TUMOR; LYMPH NODE DISSECTION; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

ACTIVINS; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; TONGUE NEOPLASMS;

EID: 84925615181     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23627     Document Type: Article

References (40)

1. Thompson CF, St John MA, Lawson G, Grogan T, Elashoff D, Mendelsohn AH,. Diagnostic value of sentinel lymph node biopsy in head and neck cancer: a meta-analysis. Eur Arch Otorhinolaryngol 2012; 270: 2115-2122.
2. Bello IO, Soini Y, Salo T,. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (II). Oral Oncol 2010; 46: 636-643.
3. Kellermann MG, Sobral LM, da Silva SD, et al. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology 2007; 51: 849-853.
4. Kellermann MG, Sobral LM, da Silva SD, et al. Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 2008; 44: 509-517.
5. Bello IO, Vered M, Dayan D, et al. Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol 2011; 47: 33-38.
6. Sobral LM, Bufalino A, Lopes MA, Graner E, Salo T, Coletta RD,. Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A. Oral Oncol 2011; 47: 840-846.
7. Chang KP, Kao HK, Liang Y, et al. Overexpression of activin A in oral squamous cell carcinoma: association with poor prognosis and tumor progression. Ann Surg Oncol 2010; 17: 1945-1956.
8. Kowalski LP, Medina JE,. Nodal metastases: predictive factors. Otolaryngol Clin North Am 1998; 31: 621-637.
9. Brandwein-Gensler M, Teixeira MS, Lewis CM, et al. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 2005; 29: 167-178.
10. Al-Rajhi N, Khafaga Y, El-Husseiny J, et al. Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol 2000; 36: 508-514.
11. Ganly I, Patel S, Shah J,. Early stage squamous cell cancer of the oral tongue-clinicopathologic features affecting outcome. Cancer 2012; 118: 101-111.
12. van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990; 177: 379-384.
13. Ross GL, Soutar DS, MacDonald DG, Shoaib T, Camilleri IG, Robertson AG,. Improved staging of cervical metastases in clinically node-negative patients with head and neck squamous cell carcinoma. Ann Surg Oncol 2004; 11: 213-218.
14. Pimenta Amaral TM, Da Silva Freire AR, Carvalho AL, Pinto CA, Kowalski LP,. Predictive factors of occult metastasis and prognosis of clinical stages I and II squamous cell carcinoma of the tongue and floor of the mouth. Oral Oncol 2004; 40: 780-786.
15. El-Naaj IA, Leiser Y, Shveis M, Sabo E, Peled M,. Incidence of oral cancer occult metastasis and survival of T1-T2N0 oral cancer patients. J Oral Maxillofac Surg 2011; 69: 2674-2679.
16. Chen YG, Wang Q, Lin SL, Chang CD, Chuang J, Ying SY,. Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp Biol Med (Maywood) 2006; 231: 534-544.
17. Ling N, Ying SY, Ueno N, et al. Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 1986; 321: 779-782.
18. Vale W, Rivier J, Vaughan J, et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986; 321: 776-779.
19. Gold E, Risbridger G,. Activins and activin antagonists in the prostate and prostate cancer. Mol Cell Endocrinol 2012; 359: 107-112.
20. Tanaka T, Toujima S, Umesaki N,. Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells. Oncol Rep 2004; 11: 875-879.
21. Yoshinaga K, Yamashita K, Mimori K, Tanaka F, Inoue H, Mori M,. Activin A causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells. Ann Surg Oncol 2008; 15: 96-103.
22. Hoda MA, Münzker J, Ghanim B, et al. Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells. Br J Cancer 2012; 107: 1978-1986.
23. Leto G, Incorvaia L, Badalamenti G, et al. Activin A circulating levels in patients with bone metastasis from breast or prostate cancer. Clin Exp Metastasis 2006; 23: 117-122.
24. Yoshinaga K, Mimori K, Yamashita K, Utsunomiya T, Inoue H, Mori M,. Clinical significance of the expression of activin A in esophageal carcinoma. Int J Oncol 2003; 22: 75-80.
25. Shimizu S, Seki N, Sugimoto T, et al. Identification of molecular targets in head and neck squamous cell carcinomas based on genome-wide gene expression profiling. Oncol Rep 2007; 18: 1489-1497.
26. Kawashiri S, Tanaka A, Noguchi N, et al. Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity. Head Neck 2009; 31: 1346-1353.
27. Vered M, Dobriyan A, Dayan D, et al. Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer. Cancer Sci 2010; 101: 274-280.
28. Marsh D, Suchak K, Moutasim KA, et al. Stromal features are predictive of disease mortality in oral cancer patients. J Pathol 2011; 223: 470-481.
29. Hinsley EE, Kumar S, Hunter KD, Whawell SA, Lambert DW,. Endothelin-1 stimulates oral fibroblasts to promote oral cancer invasion. Life Sci 2012; 91: 557-561.
30. Almangush A, Bello IO, Keski-Säntti H, et al. Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck 2013. May 21. doi: 10.1002/hed.23380 [Epub ahead of print].
31. Etemad-Moghadam S, Khalili M, Tirgary F, Alaeddini M,. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med 2009; 38: 639-643.
32. Vered M, Allon I, Buchner A, Dayan D,. Stromal myofibroblasts accompany modifications in the epithelial phenotype of tongue dysplastic and malignant lesions. Cancer Microenviron 2009; 2: 49-57.
33. Lewis MP, Lygoe KA, Nystrom ML, et al. Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 2004; 90: 822-832.
34. Byers RM, El-Naggar AK, Lee YY, et al. Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck 1998; 20: 138-144.
35. Beenken SW, Krontiras H, Maddox WA, Peters GE, Soong S, Urist MM,. T1 and T2 squamous cell carcinoma of the oral tongue: prognostic factors and the role of elective lymph node dissection. Head Neck 1999; 21: 124-130.
36. Kurokawa H, Yamashita Y, Takeda S, Zhang M, Fukuyama H, Takahashi T,. Risk factors for late cervical lymph node metastases in patients with stage I or II carcinoma of the tongue. Head Neck 2002; 24: 731-736.
37. Brandwein-Gensler M, Smith RV, Wang B, et al. Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma. Am J Surg Pathol 2010; 34: 676-688.
38. Lindenblatt Rde C, Martinez GL, Silva LE, Faria PS, Camisasca DR, Lourenço Sde Q,. Oral squamous cell carcinoma grading systems-analysis of the best survival predictor. J Oral Pathol Med 2012; 41: 34-39.
39. Li Y, Bai S, Carroll W, et al. Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma. Head Neck Pathol 2013; 7: 211-223.
40. Yang TL, Lou PJ, Chang YL, Wu CT, Wang CP, Ko JY,. Tumor satellite in predicting occult nodal metastasis of tongue cancer. Otolaryngol Head Neck Surg 2011; 145: 599-605.